NCT04300140 2023-10-30Safety and Efficacy Study of AVB-S6-500 (Batiraxcept) in Patients With Advanced or Metastatic Clear Cell Renal Cell CarcinomaAravive, Inc.Phase 1/2 Terminated72 enrolled
NCT02386111 2018-07-26A Study of Varlilumab (Anti-CD27) and Sunitinib in Patients With Metastatic Clear Cell Renal Cell CarcinomaCelldex TherapeuticsPhase 1 Terminated17 enrolled
NCT02543645 2018-04-30A Study of Varlilumab and Atezolizumab in Patients With Advanced CancerCelldex TherapeuticsPhase 1 Terminated18 enrolled
NCT01310803 2017-10-05Multi-center Study to Evaluate the Efficacy and Safety of Maintenance Therapy With Valrubicin Versus no Maintenance, in Subjects Treated With Valrubicin Induction for Carcinoma in Situ (CIS) of the BladderEndo PharmaceuticalsPhase 3 Terminated1 enrolled 5 charts
NCT00384891 2014-10-07Hyperthermia Treatment in Conjunction With Mitomycin C Versus Bacillus Calmette-Guérin Immunotherapy (BCG) for Superficial Bladder CancerMedical Enterprises Europe B.V.Phase 3 Terminated190 enrolled
NCT02013765 2014-09-25A Study of Herceptin (Trastuzumab) Monotherapy in Patients With Metastatic Urothelial CancerHoffmann-La RochePhase 2 Terminated5 enrolled 12 charts